Cure My Disease

Don't miss your cure!

 Log in / Sign up

Simple habit hacks may help cancer survivors break free from too much sitting

NCT ID NCT07694479

Recruiting now Symptom relief Sponsor: University of Toronto Source: ClinicalTrials.gov ↗

First seen Jul 10, 2026 · Last updated Jul 10, 2026

Summary

This study tests whether an 8-week habit-based program can help cancer survivors reduce the time they spend sitting or lying down during the day. Participants receive weekly tips, check-in sessions, and a Fitbit to encourage more movement. The goal is to see if the program is practical and acceptable, and whether it leads to less sedentary behavior, better physical strength, and improved quality of life.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
habit-based behavioural intervention with weekly tips, check-ins, and a Fitbit
What this could lead to
If successful, this program could offer a simple, low-cost way for cancer survivors to reduce sedentary time and improve their health and well-being.
What could go wrong
This is a small feasibility study with only 30 participants, so results may not apply to all cancer survivors. The program relies on self-motivation and may not work for everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cancer neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CANCER SEDENTARY BEHAVIOUR

Contacts and locations

Locations

  • University of Toronto - Athletic Centre

    RECRUITING

    Toronto, Ontario, M5S 2W6, Canada

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

More trials for these conditions

Other studies related to the condition(s) this trial covers.